首页> 外文期刊>Cardiovascular revascularization medicine: including molecular interventions >Left main coronary stenting in a non surgical octogenarian population: A possible approach
【24h】

Left main coronary stenting in a non surgical octogenarian population: A possible approach

机译:非外科八面体人群的左主冠状动脉支架置入术:一种可能的方法

获取原文
获取原文并翻译 | 示例
           

摘要

Coronary artery bypass grafting is conventionally considered the standard treatment for significant left main coronary artery (LMCA) disease. The management of LMCA disease in octogenarians is however still debated. The aim of this study was to appreciate the safety and effectiveness of percutaneous coronary intervention (PCI) for LMCA disease in octogenarians who were denied for surgical revascularization. The study included 70 consecutive patients ≥80 years of age who had undergone PCI for the treatment of LMCA and who were primary denied by our center's heart team for surgical revascularization. Mean age was 83.4±2.6 years. Mean Euroscore was 21.1±16.7 and mean Syntax score was 28.6±8.7. Overall in-hospital mortality was 11%. Mean follow-up time was 30.5±24.2 months. Overall mortality at the end of follow-up was 28%. Cardiac death was found in 18 patients and 2 patients died from terminal renal insufficiency. One patient (2%) presented with a new STEMI, 7 (11.3%) with a new non-STEMI, 13 (21%) with heart failure, and 2 (3.2%) had minor hemorrhage. There was a percutaneous target vessel revascularization in 6 (10%) patients. During follow-up, the total major adverse cerebral and cardiovascular event (MACCE including death, non-fatal acute myocardial infarction (AMI), target lesion revascularization (TLR), or stroke) was 27.4%. Stent implantation was relatively safely applied for the treatment of LMCA disease in octogenarians who were refused for surgery and who represented a high risk population. Despite a non-negligible rate of MACCE, the clinical long term outcome seems correct for this specific population with heavy basal status.
机译:传统上,冠状动脉搭桥术被认为是严重左主冠状动脉(LMCA)疾病的标准治疗方法。然而,对于高龄者的LMCA疾病的治疗仍存在争议。这项研究的目的是要了解经皮冠状动脉介入治疗(PCI)对于那些因手术血运重建而被拒绝的高龄人群LMCA疾病的安全性和有效性。该研究包括70例年龄≥80岁的连续患者,他们接受了PCI治疗LMCA,并且被我们中心的心脏团队拒绝进行手术血运重建。平均年龄为83.4±2.6岁。平均Euroscore为21.1±16.7,平均语法得分为28.6±8.7。总体住院死亡率为11%。平均随访时间为30.5±24.2个月。随访结束时的总死亡率为28%。发现心脏死亡18例,其中2例死于终末期肾功能不全。 1例(2%)出现新的STEMI,7例(11.3%)出现新的非STEMI,13例(21%)出现心力衰竭,2例(3.2%)出现轻度出血。 6例(10%)患者进行了经皮靶血管重建。在随访期间,总的主要不良脑和心血管事件(包括死亡,非致命性急性心肌梗死(AMI),目标病变血运重建(TLR)或中风的MACCE)为27.4%。对于那些拒绝手术且代表高危人群的八岁老人,将支架植入术相对安全地用于治疗LMCA疾病。尽管MACCE的发生率不可忽略,但对于基础状态较重的特定人群,临床长期预后似乎是正确的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号